Presented by: Tuukka Tammi, PhD
Presentation title: Developing Strategic Foresight for Drug Policy: Trends, Scenarios, and Implications
Foresight research helps us consider various future scenarios and how to prepare for them. This is crucial in drug policy where decisions can significantly impact society and people who use drugs. In his presentation, Tuukka Tammi will explore strategic foresight as a method that has so far been underutilized in social sciences and discuss its relevance for drug policy research, the tools it employs, and its practical applications. He will also share key findings from a recent study examining Finland’s drug policy trajectory toward 2030.
For further reading, the article on which the presentation is based: Unlu, A, Viskari, I, Rönkä, S, & Tammi, T (2024). Developing strategic foresight for drug policy: trends, scenarios, and implications. Drugs: Education, Prevention and Policy, 1–16. doi: 10.1080/09687637.2024.2331574
Tuukka Tammi, PhD, is a Lead Expert at the Finnish Institute for Health and Welfare (THL). His research interests are related to public and social policy analysis, health and social care system research and development, research into social problems, especially addiction research, as well as strategic foresight. Tuukka Tammi is also an associate professor (title of docent) at the Universities of Helsinki and Tampere.
Presented by: Dương Thị Hương, MD, PhD
Presentation title: DRug and Viral Infection in ViEtnam: Ending HIV Epidemic Among People Who Inject Drug in Hai Phong, Viet Nam
Dương Thị Hương is Associate Professor, Senior Lecturer, and Formal Dean of Faculty of Public Health at the Hai Phong University of Medicine and Pharmacy. Dr. Huong has had numerous projects funded by the French National Research Agency for AIDS Research (ANRS) and the National Institute on Drug Abuse focused on HIV, HCV, and related infections in people who inject drugs (PWID).
Drug Use & Infections in Vietnam (DRIVE) aimed to end the HIV epidemic among people who inject drugs in Hai Phong, Vietnam (NIDA R01DA041978/ANRS 12353) and ran from 2016 to 2021. DRIVE has been a foundation for several subsequent initiatives, including DRIVE-C (Drug Use & Infections in Vietnam – Hepatitis C) (ANRS 12380), which focused on HCV elimination; DRIVE-MIND Mental Health Intervention for Injecting Drug Users, (ANRS 12410); DRIVE-COVID (ANRS COV22), which evaluated the impact of lockdown measures on HIV and HCV risk behaviors and access to prevention and care during the COVID-19 epidemic for PWID in Hai Phong; and DRIVE-TB Tuberculosis Control, (ANRS 0092, co-funded by NIDA, ANRS|MIE, and L’initiative-Expertise France), aimed at tuberculosis elimination among PWIDs. These projects have resulted in publications in over 20 international journals. The Community HIV Epidemiological Evaluation and Response (CHEER) program has utilized the DRIVE model to evaluate the HIV epidemic in other provinces.